Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Nature Reviews. Drug Discovery|October 10, 2009
The future of drug development: advancing clinical trial designJohn Orloff, Frank Douglas, Jose Pinheiro, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
Dose-response modeling of occupational exposure to polycyclic aromatic hydrocarbons with biomarkers of exposure and effectBeate Pesch, Martin Kappler, Kurt Straif, et al.Eclinicalmedicine|November 8, 2024
Efficacy and safety of asunercept, a CD95L-selective inhibitor, in hospitalised patients with moderate-to-severe COVID-19: ASUNCTIS, a multicentre, randomised, open-label, controlled, phase 2 trialMaria Pilar Ruiz Seco, José Ramón Paño Pardo, Christian Schoergenhofer, et al.International Clinical Psychopharmacology|February 27, 2026
Depression severity and efficacy outcomes: post hoc analyses from a phase 3 trial of esmethadone for the adjunctive treatment of major depressive disorder with inadequate response to standard antidepressantsClotilde Guidetti, George I Papakostas, Steven Stahl, et al.Journal of the American College of Cardiology|April 16, 2021
Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the WeekJames L Januzzi, John M Canty, Saumya Das, et al.The Lancet. Oncology|August 4, 2015
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 studyFarhad Ravandi, Ellen K Ritchie, Hamid Sayar, et al.Pain|May 29, 2014
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.Pageof 5